Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults

被引:39
|
作者
Hilpert, KF [1 ]
Kris-Etherton, PM
West, SG
机构
[1] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA
[2] Penn State Univ, Huck Inst Lifes Sci, University Pk, PA 16802 USA
[3] Penn State Univ, Dept Behav Hlth, University Pk, PA 16802 USA
关键词
inflammation; cholesterol; diet; isoflavones; hormone replacement therapy;
D O I
10.1093/jn/135.5.1075
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Recent evidence suggests that individuals with high concentrations of C-reactive protein (CRP), a marker of inflammation, are less responsive to cholesterol-lowering diets. CRP concentrations are increased by oral estrogen; however, the effect of soy phytoestrogens on inflammation has not been studied comprehensively, especially in women receiving hormone replacement therapy (HRT). This study was conducted to determine whether adding soy to a low-fat, high-fiber diet affects CRP and interleukin (IL)-6, and to examine the association between CRP levels and lipid response in moderately hypercholesterolemic adults (men = 18, postmenopausal women = 14; 6 receiving HRT). After a 3-wk run-in period with consumption of a Step 1 diet (27% total fat, 7% saturated fat, 275 mg cholesterol), participants were randomly assigned to diets containing 25 g/d soy protein (+ 90 mg/d isoflavones) or 25 g/d milk protein for 6 wk in a crossover design. Lipids and lipoproteins, CRP, and IL-6 were measured at the end of each diet and participants were categorized into high (> 3.5 mg/L) or low CRP groups based on a median split. The addition of soy or milk protein to the Step I diet did not affect lipids or inflammatory markers. Regardless of protein source, those with low CRP exhibited significant decreases in LDL cholesterol (-3.5%) and the LDL:HDL cholesterol ratio (-4.8%), whereas those with high CRP had significant increases in LDL cholesterol (+4.8%), the LDL:HDL cholesterol ratio (+5.2%), apolipoprotein B (+3.8%), and lipoprotein(a) (+13.5%) compared with the run-in diet. These results suggest that inflammation may not only attenuate lipid responses, but also aggravate dyslipidemia in hypercholesterolemic subjects consuming a cholesterol-lowering diet.
引用
收藏
页码:1075 / 1079
页数:5
相关论文
共 49 条
  • [41] Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP
    Jublanc, C
    Bruckert, E
    Giral, P
    Chapman, MJ
    Leenhardt, L
    Carreau, V
    Turpin, G
    ATHEROSCLEROSIS, 2004, 172 (01) : 7 - 11
  • [42] Synergistic effects of overweight/obesity and high hemoglobin A1c status on elevated high-sensitivity C-reactive protein in Chinese adults: a cross-sectional study
    Shen, Qianqian
    He, Tingchao
    Li, Ting
    Szeto, Ignatius Man-Yau
    Mao, Shuai
    Zhong, Wuxian
    Li, Pin
    Jiang, Hua
    Zhang, Yumei
    FRONTIERS IN NUTRITION, 2023, 10
  • [43] A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study
    Saito, Isao
    Sato, Shinichi
    Nakamura, Masakazu
    Kokubo, Yoshihiro
    Mannami, Toshifumi
    Adachi, Hisashi
    Konishi, Masamitsu
    Okada, Katsutoshi
    Iso, Hiroyasu
    Kario, Kazuomi
    Ohsuzu, Fumitaka
    Momiyama, Yukihiko
    Tsushima, Motoo
    ATHEROSCLEROSIS, 2007, 194 (01) : 238 - 244
  • [44] Serum high sensitive C-reactive protein level and its correlation with lipid profile among dyspeptic patients with or without Helicobacter pylori infection in East Gojjam zone, Ethiopia
    Baye, Gelagey
    Wondmneh, Bayu
    Ashenef, Baye
    Jemal, Mohammed
    Baylie, Temesgen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [45] Reaching C-Reactive Protein and Low-Density Lipoprotein Cholesterol Goals in Dyslipidemic Patients (from the Lipid Treatment Assessment Project [L-TAP] 2)
    Chiang, Cheng-Wen
    Santos, Raul D.
    Waters, David D.
    Messig, Michael
    Tarasenko, Lisa
    Jukema, J. Wouter
    Ferrieres, Jean
    Foody, JoAnne
    Seung, Ki-Bae
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (11) : 1639 - 1643
  • [46] Effect of ethinyl estradiol/norethisterone acetate with and without scaling on periodontal status and high-sensitivity C-reactive protein levels in women with polycystic ovary syndrome having gingivitis: a randomized controlled trial
    Verma, Richa
    Tewari, Shikha
    Singhai, Savita Rani
    Sangwan, Aditi
    QUINTESSENCE INTERNATIONAL, 2024, 55 (10): : 792 - 802
  • [47] Efficacy and safety of liraglutide on C-reactive protein (CRP) in adults with type 2 diabetes: A GRADE-assessed systematic review and dose-response meta-analysis of controlled trials
    Mozaffari, Nazanin
    Bideshki, Mohammad Vesal
    Sartang, Mohsen Mohammadi
    Behzadi, Mehrdad
    PHARMANUTRITION, 2024, 30
  • [48] Prevalence of metabolic syndrome (MetS) in stable Chronic Obstructive Pulmonary Disease (COPD) patients and status of c-reactive protein among COPD patients with and without MetS visiting Tribhuvan University Teaching Hospital, Nepal
    Baniya, Santosh
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [49] Effect of Rosuvastatin on Concentrations of Plasma Lipids, Urine and Plasma Oxidative Stress Markers, and Plasma High-Sensitivity C-Reactive Protein in Hypercholesterolemic Patients With and Without Type 2 Diabetes Mellitus: A 12-Week, Open-Label, Pilot Study
    Yoshino, Gen
    Tanaka, Manabu
    Nakano, Saburo
    Matsumoto, Tomoko
    Kojima, Masato
    Murakami, Eiichi
    Morita, Toshisuke
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2009, 70 (06): : 439 - 448